Study of Diagnostic Performance of [18F]CTT1057 for PSMA-positive Tumors Detection
Clinical trial NCT04838626 · COMPLETED
Trial details
- NCT number
- NCT04838626
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-07
- Primary completion
- 2023-11-24
- Enrollment
- 195
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.